Market Report Source

Overview

The purpose of this TriMark Publications report is to describe the specific market segment of the in vitro diagnostics market called point of care testing (POCT). It examines these clinical measurement devices and their reagents and supplies as utilized in hospitals, clinics and doctor’s offices. An analysis of analytes that are related to the common chemical constituents of blood, plasma or serum at the point of care of the patient is addressed.

Moreover, the study defines the dollar volume of sales, both worldwide and in the U.S., and analyzes the factors that influence the size and the growth of the market segments. Also examined are the subsections of each market segment, including the research labs, hospital labs and commercial laboratories. Additionally, rapid detection of food pathogens and infectious pathogens (MSRA, herpes simplex, avian flu, West Nile virus and typhoid) are discussed.

The report surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the point of care market in the U.S. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company’s market position.

Table of Contents

1. Overview
1.1 About this Report
1.2 Scope of the Report
1.3 Objectives
1.4 Methodology
1.5 Executive Summary

2. Overview of Diagnostic Testing Point of Care
2.1 POCT Testing Sites
2.2 POCT Market Structure
2.3 New Directions in Clinical IVD Testing

3. POC and Rapid Testing: Market Analysis: Size, Background Analysis, Growth, Share and Competitors
3.1 Global POCT Market
3.2 U.S. POCT Markets
3.3 European POCT Market
3.3.1 German Point of Care Diagnostic Markets
3.3.2 U.K. POCT Diagnostic Market
3.3.2.1 U.K. POC Market Statistics
3.3.2.2 U.K. Competitive Analysis
3.3.2.3 U.K. Market Access
3.3.3 French Point of Care Diagnostic Market
3.3.4 Italian POC Diagnostic Market
3.3.5 Spanish POC Diagnostic Market
3.3.6 Scandinavian Point of Care Market
3.3.7 Swedish POCT Market
3.3.8 Finland POCT Market
3.3. 9 Norway POCT Market
3.3.10 Swiss POCT Market
3.3.11 Dutch Clinical Laboratory Diagnostic Market
3.3.12 Belgian Clinical Laboratory Diagnostic Market
3.3.13 Portugal Clinical Laboratory Diagnostic Market
3.3.14 Austria Clinical Laboratory Diagnostic Market
3.3.15 Greece Clinical Laboratory Diagnostic Market
3.3.16 Poland Clinical Laboratory Diagnostic Market
3.3.17 Czech Republic Clinical Laboratory Diagnostic Market
3.3.18 Turkey Point of Care Market
3.4 Asian POCT Markets
3.4.1 Japanese POCT Market
3.4.2 Indian POCT Market
3.4.3 Chinese Point of Care Market
3.5 Rest of the World POCT Market
3.5.1 Canada Point of Care Market
3.5.2 Brazil Point of Care Market
3.5.3 Australia Point of Care Market
3.6 Overview of Asian Healthcare Market
3.6.1 Singapore
3.6.2 Malaysia
3.6.3 Thailand
3.6.4 Indonesia
3.6.5 Philippines
3.6.6 South Korea
3.6.7 Taiwan

4. POCT Individual Markets
4.1 Glucose Testing
4.2 POCT Individual Market Sectors, Size, Growth Rates and Competitors
4.2.1 U.S. Market
4.2.2 European Market
4.2.3 Alternate Glucose Monitoring Products
4.3 Blood Gas and Electrolytes
4.4 Rapid Coagulation Tests
4.4.1 U.S. Coagulation Market
4.4.2 European Coagulation Market
4.5 Rapid Cardiac Markers
4.5.1 American Market
4.5.2 European Market
4.6 Drugs of Abuse Screening Testing
4.6.1 Acetaminophen
4.6.2 TriCyclic Antidepressants
4.6.3 Other Toxic Drugs
4.6.4 Drug Testing Selectivity
4.6.5 Methaqualone and Phencyclidine (PCP)
4.6.6 Tetrahydrocannabinol
4.6.7 Drug Panels by Toxidromes
4.6.8 Alcohol Testing
4.7 Urine Strips
4.8 Pregnancy Tests
4.9 Fecal Occult Blood
4.10 Hemoglobin Testing
4.11 Miscellaneous Rapid Tests
4.11.1 Estriol
4.11.2 Fetal Fibrinectin (fFN)
4.11.3 H. pylori
4.11.4 Vaginal pH and Vaginitis
4.11.5 Bladder Cancer
4.11.6 Fetal Status
4.12 HIV
4.13 Cholesterol
4.14 Infectious Disease
4.14.1 C. difficile
4.14.2 Giardia
4.14.3 Salmonella and Campylobacter
4.14.4 Malaria Testing
4.14.5 Influenza Testing
4.14.6 Strep Testing
4.14.7 Chlamydia
4.14.8 Mononucleosis
4.14.9 Rubella
4.14.10 Staphylococcus Aurea
4.14.11 Hepatitis
4.14.12 Gonorrhea
4.14.13 Tuberculosis (TB)
4.14.14 Herpes Simplex Virus Type-2
4.15 Infant Jaundice
4.16 Anthrax
4.15 Ruptured of Fetal Membranes (ROM)
4.16 Food Pathogens
4.17 Typhoid

5. POCT: Reagents and Equipment
5.1 Blood Glucose Monitoring
5.2 Blood Gas and Electrolytes
5.2.1 Optical Sensors
5.2.2 Roche Corp.
5.2.3 TechnoMedica
5.2.4 Bayer
5.2.5 Instrumentation Laboratory
5.2.6 Nova Biomedical
5.2.7 Radiometer
5.2.8 Abbott (i-STAT Corporation)
5.2.9 Avox Systems
5.2.10 Disetronic Medical Systems
5.2.11 Nova
5.2.12 Abbott
5.2.13 ITC
5.2.14 Osmetech
5.2.15 Span Diagnostics
5.3 Rapid Coagulation Tests
5.3.1 POC Coagulation Instrument Description
5.3.1.1 Roche Diagnostics Corp.
5.3.1.2 Abbott i-STAT
5.3.1.3 International Technidyne Corp.
5.3.1.4 Medtronic Cardiac Surgery
5.3.1.5 LifeScan
5.3.1.6 Instrumentation Laboratory
5.3.1.7 Hemosense
5.3.1.8 Helena Point of Care
5.3.1.9 Bayer
5.3.1.10 Beckman Coulter
5.3.1.11 Pharmanetics (Cardiovascular Diagnostics)
5.3.1.12 Sienco
5.3.1.13 Accumetrics
5.3.2 Connectivity Issues
5.3.3 Cost Benefits
5.3.4 Quality Control Issues
5.3.5 Certification for POC Coagulation Devices
5.3.6 Systems for ACT
5.4 Rapid Cardiac Markers
5.4.1 Spectral Diagnostics
5.4.2 Biosite Diagnostics
5.4.3 Roche Diagnostics
5.4.4 First Medical
5.4.5 Ani Biotech
5.4.6 Response Biomedical
5.4.7 Dade Behring
5.4.8 SYN•X Pharma, Inc.
5.4.9 Ark Therapeutics Ltd.
5.4.10 Abbott (i-STAT Corp.)
5.4.11 LifeSign
5.4.12 Mitsubishi Kagaku Iatron
5.5 Rapid Drugs of Abuse
5.5.1 Biosite Diagnostics
5.5.2 Point of Care Technologies
5.5.3 Abbott Diagnostics
5.5.4 Roche Diagnostics
5.5.5 BioScan Screening Systems, Inc.
5.5.6 American Bio Medica Corp.
5.5.7 Pharmatech Corporation
5.5.8 Worldwide Medical
5.5.9 Syva Dade Behring
5.5.10 STC Technologies Inc.
5.5.11 Dynagen Inc.
5.5.12 Orasure
5.5.13 LifePoint
5.5.14 Avitar, Inc.
5.5.15 Cozart Biosciences
5.5.16 GDS
5.5.17 Securetec
5.6 Urine Strips
5.7 Rapid Pregnancy and Fertility Tests
5.8 Fecal Occult Blood
5.8.1 Helena Laboratories
5.8.2 Biomerica
5.8.3 Beckman Coulter
5.8.4 Wampole Laboratories
5.8.5 Worldwide Medical
5.8.6 Aerscher Diagnostics
5.8.7 Enterix
5.8.8 Medix Biochemica
5.9 Hemoglobin Testing
5.9.1 Wampole Laboratories
5.9.2 HemoCue, Inc.
5.9.3 Micro Diagnostics Corporation
5.9.4 GDS Technology
5.10 Miscellaneous Rapid Tests
5.10.1 Triage C. difficile Panel
5.10.2 Ketoacids
5.10.3 Acetaminophen
5.10.4 Estriol
5.10.5 H. pylori
5.10.6 Vaginal Fluid pH and Vaginitis
5.10.7 PSA
5.10.8 Bladder Cancer
5.10.9 Other Rapid Cancer Tests
5.10.10 Fetal Status
5.10.11 Osteoporosis
5.11 HIV
5.12 Cholesterol
5.12.1 Cholestech
5.12.2 Lifestream Diagnostics
5.12.3 Actimed Laboratories
5.12.4 Stat Site Meter
5.12.5 Polymer Technology Systems
5.12.6 International Medical Innovations Inc. (IMI)
5.13 Infectious Disease
5.13.1 C. difficile
5.13.2 Giardia
5.13.3 Dengue Fever
5.13.4 Malaria Testing
5.13.5 Rapid Influenza Testing
5.13.6 Streptococcus Testing
5.13.7 Chlamydia
5.13.8 Mononucleosis
5.13.9 Rubella
5.13.10 Staphylococcus
5.13.11 Hepatitis
5.13.12 E. coli 0157
5.13.13 Gonorrhea Testing
5.13.14 Small Pox
5.13.15 SARS
5.13.16 Rabies
5.13.17 Tuberculosis
5.13.18 Avian Flu
5.13.19 West Nile Virus
5.13.20 Herpes Simplex Virus Type-2
5.14 Infant Jaundice
5.15 Anthrax
5.16 Homeland Defense
5.17 BSE
5.18 Tuberculosis
5.19 Typhoid
5.20 Asian Flu
5.21 Food Pathogens (Salmonella, Listeria, Campylobacter)
5.22 Ruptured Fetal Membranes (ROM)

6. POCT: Growth Regulators
6.1 Moderators of Growth
6.2 Personnel Acceptance
6.3 Key People for POCT
6.4 Information Management Issues
6.4.1 Elements of Information Management for POCT: Information Processing Capabilities
6.4.2 Data Mining
6.4.3 Middleware
6.4.4 Web Portals
6.4.5 POCT-1A Standard
6.5 Key Elements for POCT
6.6 POCT and Reimbursement
6.7 Effectiveness of Clinical Outcomes
6.8 Rapid Near Patient Testing in Hospitals
6.9 Satellite Facilities
6.10 Regionalization of Laboratory Care
6.11 Requirements for POCT
6.12 Locations of Point of Care for Patient Care
6.13 Benefits of POCT
6.14 TAT for POCT
6.15 Clinical Laboratory Improvement Amendments (CLIA)
6.16 Sexually Transmitted Diseases in Underdeveloped Countries

7. Business Trends in the Point of Care Sector
7.1 Sector Consolidation
7.2 Diagnostic Testing Growth Trends
7.3 Acquisition, License Agreements, Internal Development, Partnerships
7.4 Product Testing Depth in POCT
7.5 Government Regulation
7.5.1 U.S. Regulation
7.5.1.1 Importing Medical Devices into the U.S.
7.5.1.2 Exporting Medical Devices from the U.S.
7.5.2 U.K. Regulation
7.5.3 E.U. Regulation
7.5.3.1 French Regulation
7.5.4 Japanese Regulation
7.5.5 Korean Regulation
7.6 Increased Market Penetration
7.7 Costs of Doing Business in Europe
7.8 Drivers of European Diagnostics Testing
7.9 European Reimbursement Practices
7.10 Cost Containment in Europe

8. Technology Platform Innovations in POCT
8.1 Sensor Systems for Diagnostic Applications
8.2 Glucose Measurements
8.3 Glucose Test Methods
8.4 Cholesterol Testing
8.5 The New Paradigm
8.6 Consolidated Workstations and Modularity
8.7 Automation and Robotics in the Clinical Laboratory
8.8 Laboratory Information Systems (LIS)
8.9 Biosensor Technology

9. Data Management and Connectivity
9.1 Wireless LANs
9.2 Connectivity Platforms
9.2.1 DataLink Data Management System
9.2.2 RALS-Plus
9.2.3 LabPortal.com
9.3 Advantages of POCT Connectivity

10. Corporate Profiles
10.1 Abaxis, Inc.
10.2 Abbott Diagnostics
10.3 Accumetrics, Inc.
10.4 Accurex Biomedical, Pvt., Ltd.
10.5 ActiMed Diagnostics
10.6 Adeza Biomedical Corporation
10.7 Akers Bioscience
10.8 Ambri Ltd.
10.9 American Biogenetic Sciences, Inc.
10.10 American Bio Medica Corp.
10.11 Ani Biotech
10.12 Apogent Technologies
10.13 Ark Therapeutics
10.14 Arkray
10.15 Array Medical
10.16 Atlas Genetics
10.17 Autonomics
10.18 Avitar, Inc.
10.19 Avox Systems
10.20 Axis-Shield
10.21 Bayer Corporation
10.22 Beacon Diagnostics
10.23 Beckman Coulter
10.24 Biex Inc.
10.25 Binax Corporation
10.26 Biomerica
10.27 BioMérieux Vitek, Inc.
10.28 BioScan Screening Systems, Inc.
10.29 Biosite Diagnostics
10.30 BioStar
10.31 Bio-Warm Corporation
10.32 British Biocell Holdings
10.33 Caliper Life Sciences
10.34 Calypte Biomedical
10.35 Cardiovascular Diagnostics
10.36 Chembio Diagnostics
10.37 ChemTrak
10.38 Cholestech
10.39 Chongqing Sungene Pharmaceutical Co., Ltd.
10.40 Compucyte Corporation
10.41 Cortech Diagnostics Ltd.
10.42 Cozart Biosciences
10.43 Cygnus Therapeutic Systems
10.44 Cytogen
10.45 Dade Behring
10.46 Daiichi Co., Ltd.
10.47 Denka Seiken Co., Ltd.
10.48 Diagnology, Inc.
10.49 Ely Labs
10.50 Enterix, Inc.
10.51 First Medical, Inc.
10.52 Focus Diagnostics, Inc.
10.53 GDS Technology
10.54 GenBio
10.55 Genzyme Diagnostics
10.56 Grant Life Sciences
10.57 Gryphus Diagnostics
10.58 Helena Laboratories
10.59 Hema Diagnostic Systems
10.60 Hemocue, Inc.
10.61 Home Access Health Corp.
10.62 i-STAT Corporation
10.63 Instrumentation Laboratory
10.64 International Medical Innovations
10.65 Inverness Medical Innovations
10.66 Immunoscience, Inc.
10.67 Jiangnan Biotech
10.68 Johnson & Johnson
10.69 Kuerkeji Biotech
10.70 Kyowa Medex Co., Ltd.
10.71 LifeAssays
10.72 LifePoint, Inc.
10.73 LifeScan Corporation
10.74 Lifestream Technologies
10.75 LXN Corp. (Inverness Medical Technologies)
10.76 Matritech
10.77 Medical Services International Inc.
10.78 MediSense
10.79 Medisys
10.80 Medix Biochemica
10.81 MedMira Laboratories
10.82 Meretek Corporation
10.83 Meridian Bioscience
10.84 MiniMed
10.85 Mitsubishi Chemical America, Inc.
10.86 Mitsubishi Kagaku Iatron
10.87 Nanogen
10.88 New Horizons Diagnostics
10.89 Nova Diagnostics
10.90 Optical Sensors Inc.
10.91 Orasure
10.92 Orgenics
10.93 Orion Diagnostica
10.94 PanBio Corp.
10.95 PharmaNetics, Inc.
10.96 Pharmatech Corporation
10.97 Phillips Medical Systems
10.98 Point of Care Technologies
10.99 Polymedco
10.100 Polymer Technology Systems
10.101 Princeton BioMeditech Corporation
10.102 Quidel
10.103 Radiometer
10.104 Response Biomedical Corp.
10.105 Roche Diagnostics
10.106 Royal Philips Electronics
10.107 Saliva Diagnostics
10.108 Savyon Diagnostics
10.109 Selfcare, Inc.
10.110 Shanghai Siic Kehua Biotech Co., Ltd. (Kehua Biotech)
10.111 Shionogi & Co., Ltd.
10.112 SpectRx, Inc.
10.113 Spectral Diagnostics
10.114 STC Technologies
10.115 Strategic Diagnostics
10.116 Sun Biomedical Laboratories
10.117 Sybron International Corporation
10.118 Taiwan Diagnostic
10.119 TCPI
10.120 Therasense, Inc.
10.121 Thermo Biostar
10.122 Thoratec/International Technidyne Corp.
10.123 Transmedica
10.124 Trinity Biotech
10.125 Venkateshwara Hatcheries Pvt. Ltd.
10.126 Wampole Laboratories
10.127 Worldwide Medical Corporation

11. POCT Sector Trends and Forecasts

12. Corporate Directory

LIST OF FIGURES

Figure 6.1: Percent Distribution of Emergency Room Visits in the U.S., 2004
Figure 6.2: Annual Rate of Emergency Room Visits By Primary Expected Source of Payment: U.S., 2004

INDEX OF TABLES

Table 2.1: POC Testing
Table 3.1: Number of ER Visits in U.S. Hospitals, 1997-2004
Table 3.2: Number of Point of Care Tests in U.S., 2000-2012
Table 3.3: Global Clinical Laboratory Market Sales, 1998-2010
Table 3.4: The Overall in Vitro Diagnostic Testing Market Worldwide in 2006
Table 3.5: Worldwide Distribution of IVD Testing in 2006
Table 3.6: Top Twelve Country IVD Testing Markets, 2005
Table 3.7: Fifteen Largest Diagnostic Companies Worldwide, 2005
Table 3.8: Global Point of Care Revenues, 1998-2008
Table 3.9: Worldwide Distribution of POCT, 2005
Table 3.10: U.S. Clinical Laboratory Testing Market, 2003-2012
Table 3.11: U.S. Clinical Laboratory Diagnostic Test Market Segments by Location of Analysis, 2006
Table 3.12: U.S. POCT Market, 2000-2011
Table 3.13: U.S. POCT by Distribution Location, 2005
Table 3.14: U.S. Clinical Diagnostic POCT and Rapid Test Market Segments, 2005
Table 3.15: European Clinical Laboratory Testing IVD Reagents and Instruments Market, 2000-2012
Table 3.16: European Clinical Laboratory Testing IVD Reagents and Instruments Market, 2000-2012
Table 3.17: European Clinical Laboratory Testing Diagnostics by Country Market Estimates, 2006
Table 3.18: European Rapid Point of Care Testing by Country Market Estimates, 2006
Table 3.19: Drivers of European Diagnostics Testing
Table 3.20: Regional Comparison of Healthcare Spending for IVD for Eastern Europe
Table 3.21: European POCT Market, 2000-2010
Table 3.22: Top Twelve Country IVD Testing Markets and POC Share, 2005
Table 3.23: German Clinical Laboratory Testing Diagnostics Products Market Sales, 2003-2012
Table 3.24: German POCT Diagnostics Products Market Sales, 2003-2012
Table 3.25: German Clinical Diagnostic Rapid Test Market Segments, 2006
Table 3.26: U.K. Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.27: U.K. Clinical Reagents and Instruments Markets, 2006
Table 3.28: U.K. POCT Diagnostics Products Market Sales, 2006-2012
Table 3.29: UK Clinical Diagnostic Rapid Test Market Segments, 2006
Table 3.30: Major U.K. IVD Manufacturers
Table 3.31: U.S. IVD Manufacturers Doing Business in the U.K.
Table 3.32: Other European Companies that Manufacture IVD Products in the U.K.
Table 3.33: French Clinical IVD Testing Diagnostics Products Market Sales, 2003-2012
Table 3.34: French Clinical IVD Reagents and Instruments Markets, 2006
Table 3.35: French POC Diagnostics Products Market Sales, 2005-2012
Table 3.36: French Clinical Diagnostic Rapid Test Market Segments, 2006
Table 3.37: Italian Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.38: Italian Clinical Reagents and Instruments Markets, 2006
Table 3.39: Italian POC Diagnostics Products Market Sales, 2005-2012
Table 3.40: Italian Clinical Diagnostic Rapid Test Market Segments, 2006
Table 3.41: Spanish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.42: Spanish Clinical Reagents and Instruments Markets, 2006
Table 3.43: Spanish POC Diagnostics Products Market Sales, 2005-2012
Table 3.44: Spanish Clinical Diagnostic Rapid Test Market Segments, 2006
Table 3.45: Scandinavian POCT Diagnostics Products Market Sales, 2000-2012
Table 3.46: Swedish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.47: Swedish Clinical Reagents and Instruments Markets, 2006
Table 3.48: Swedish POC Diagnostics Products Market Sales, 2005-2012
Table 3.49: Finnish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.50: Finnish Clinical Reagents and Instruments Markets, 2006
Table 3.51: Finnish POC Diagnostics Products Market Sales, 2005-2012
Table 3.52: Norwegian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.53: Norwegian Clinical Reagents and Instruments Markets, 2006
Table 3.54: Norwegian POC Diagnostics Products Market Sales, 2005-2012
Table 3.55: Swiss Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.56: Swiss Clinical Reagents and Instruments Markets, 2006
Table 3.57: Swiss POCT Diagnostics Products Market Sales, 2005-2012
Table 3.58: Dutch Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.59: Dutch POC Diagnostics Products Market Sales, 2005-2012
Table 3.60: Belgium Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.61: Belgium POCT Diagnostics Products Market Sales, 2005-2012
Table 3.62: Portugeese Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.63: Portugeese POCT Diagnostics Products Market Sales, 2005-2012
Table 3.64: Austrian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.65: Austrian Clinical Reagents and Instruments Markets, 2006
Table 3.66: Austrian POCT Diagnostics Products Market Sales, 2005-2012
Table 3.67: Greek Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.68: Greek POCT Diagnostics Products Market Sales, 2005-2012
Table 3.69: Polish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.70: Polish POCT Diagnostics Products Market Sales, 2005-2012
Table 3.71: Czech Clinical Laboratory Diagnostics Products Market Sales, 2004-2012
Table 3.72: Czech POCT Diagnostics Products Market Sales, 2005-2012
Table 3.73: Turkish POCT Market, 2000-2012
Table 3.74: Japanese Medical Device Market Size, 1997-2003
Table 3.75: Japan Point of Care Testing Market, 2000-2008
Table 3.76: Japanese Population and Aging Demographics Forecast, 2000-2050
Table 3.77: Indian IVD Market for Instruments and Reagents, 1996-2012
Table 3.78: Number of Automated Clinical Labs in India, 2004-2012
Table 3.79: Indian IVD Market, 2006
Table 3.80: Market Sales of IVD Equipment and Reagents by Company in India, 2004 and 2005
Table 3.81: Market Sales of IVD Equipment and Reagents by Company in India, 2004 and 2005
Table 3.82: Indian Point of Care Diagnostics Products Market Sales, 2000-2008
Table 3.83: Chinese IVD Market, 2006-2012
Table 3.84: Number of Automated Clinical Labs in China, 2004-2012
Table 3.85: Chinese IVD Market, 2006
Table 3.86: Chinese Point of Care Diagnostics Products Market Sales, 2000-2008
Table 3.87: The Rest of the World POCT Market, 2000-2012
Table 3.88: Canadian POCT Market, 2000-2012
Table 3.89: Brazilian POCT Market, 2000-2012
Table 3.90: Australian POCT Market, 2000-2012
Table 4.1: World Market Share of Point of Care Glucose Monitoring Marketers
Table 4.2: The Global Population of Persons with Diabetes, 1995 and 2025
Table 4.3: U.S. Point of Care Glucose Testing Market, 1997-2011
Table 4.4: Manufacturer Market Share U.S. POCT Market, 2005
Table 4.5: Rapid Testing U.S. Market Share for Blood Glucose Testing Segment
Table 4.6: The Blood Gas and Electrolyte Market for POCT in the U.S., 2001-2011
Table 4.7: Manufacturer Market Share U.S. POCT Blood Gas and Electrolytes Market, 2005
Table 4.8: The Coagulation Market for POCT in the U.S., 2001-2011
Table 4.9: The POC Prothrombin Market for POCT in the U.S., 2000-2007
Table 4.10: The Cardiac Marker Market for POCT in the U.S., 2001-2011
Table 4.11: Manufacturer Market Share U.S. POCT Cardiac Marker Market, 2005
Table 4.12: The Cardiac Marker Market for POCT in Europe, 2001-2011
Table 4.13: U.S. Point of Care Drugs of Abuse Testing Market, 2001-2011
Table 4.14: Global Point of Care Urine Test Strip Testing Market, 2001-2007
Table 4.15: U.S. Point of Care Urine Test Strip Testing Market, 2001-2011
Table 4.16: U.S. Point of Care Urine Test Strip Testing Market Share
Table 4.17: Medicare Fee Schedule for Urine Chemistry Testing
Table 4.18: U.S. Point of Care Pregnancy Testing Market, 2001-2007
Table 4.19: International Point of Care Pregnancy Testing Markets, 2001-2007
Table 4.20: U.S. Market Share for Rapid Point of Care Pregnancy Tests
Table 4.21: Number of HIV Tests Performed in Europe, 1997-2001
Table 4.22: U.S. POCT Market for HIV, 2001-2008
Table 4.23: Countries with the Highest Prevalence of HIV/AIDS
Table 4.24: Births of HIV Infected Babies in U.S., 1991-2001
Table 4.25: Salmonella Testing Market, 2002-2007
Table 4.26: Worldwide Point of Care Influenza Testing Market, 2002-2007
Table 4.27: U.S. Point of Care Influenza Testing Market, 2002-2007
Table 4.28: International Point of Care Influenza Testing Markets, 2002-2007
Table 4.29: U.S. Market for Rapid Point of Care Influenza Tests, 2005
Table 4.30: Worldwide Point of Care Strep A Testing Market, 2002-2007
Table 4.31: U.S. Point of Care Strep A Testing Market, 2002-2007
Table 4.32: International Point of Care Strep A Testing Markets, 2002-2007
Table 4.33: U.S. Market for Rapid Point of Care for Group A Strep Tests
Table 4.34: Global Market for Chlamydia Diagnostic Testing, 2000-2009
Table 4.35: U.S. Market for Chlamydia Diagnostic Testing, 2000-2009
Table 4.36: Global Market for Gonorrhea Diagnostic Testing, 2000-2009
Table 4.37: Global Market for TB Diagnostic Testing, 2000-2008
Table 4.38: U.S. Anthrax Test Market
Table 5.1: Type of Test: Lateral Flow
Table 5.2: Type of Test: Flow-Through
Table 5.3: Type of Test: Agglutination
Table 5.4: Type of Test: Immunoblot
Table 6.1: Visits per ER in the U.S., 1997-2001
Table 6.2: ER Admissions in the U.S., 1997-2004
Table 6.3: Access Points
Table 6.4: Desktop Adapters-One Computer
Table 6.5: Desktop Adapters-Four Computers
Table 6.6: PCMCIA Adapters
Table 6.7: POCT Clinical Outcomes in Diabetic Ketoacidosis
Table 6.8: POCT Clinical Outcomes in Arterial Blood Gas Measurements
Table 6.9: POCT in Three Hospitals Cost Analysis with Labor Included
Table 6.10: Cost Analysis for Glucose Testing: POCT vs. Central Lab
Table 6.11: Financial Comparison for Moderate and Waived CLIA Labs
Table 8.1: Normal Glucose Values-Fasting State
Table 9.1: Applications for Wireless LAN Technology
Table 9.2: Wireless LAN Technology Companies
Table 9.3: Customized Reports Must Support CAP and JCAHO Requirements
Table 9.4 RALS-Plus Point of Care Market Share
Table 9.5: Applications of RALS Connectivity with POCT Devices
Table 10.1: Products Marketed by Abbott in the Diagnostic Market
Table 10.2: Quidel Product Sales Distribution and Sales, 2006